Physician profile
Robert M Arnett
NPI 1518914449
$683.76
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $527 · 2020: $68.16 · 2021: $88.54.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $190.39 | 2019-2021 | |
| Astellas Pharma US INC | $74.55 | 2019-2020 | |
| Amgen INC. | $65.90 | 2019-2020 | |
| Daiichi Sankyo INC. | $62.49 | 2019 | |
| Amag Pharmaceuticals, INC. | $49.48 | 2019 | |
| Avion Pharmaceuticals | $40.00 | 2019 | |
| Pfizer INC. | $34.12 | 2019 | |
| Therapeuticsmd, INC. | $33.24 | 2019 | |
| Roche Diagnostics Corporation | $22.36 | 2019 | |
| Exeltis, USA INC. | $19.06 | 2021 | |
| Covidien LP | $18.31 | 2019 | |
| Agile Therapeutics, INC. | $17.65 | 2021 | |
| Evofem Biosciences, INC. | $17.23 | 2021 | |
| Smith+Nephew, INC. | $15.01 | 2019 | |
| Lupin INC. | $12.44 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $11.53 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Arnett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.